Jakub Svoboda

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster, Jakub Svoboda, Elise A. Chong et al. · New England Journal of Medicine · 2017 · 1.9K citations · Full text

Life Sciences, Hematology, Immunology +17

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 452 citations · Full text

Medicine, Oncology, Pharmacology +12

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 309 citations · Full text

Life Sciences, Immunology, Microbiology +14

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

Philippe Armand, Scott J. Rodig, Catherine Thiéblemont et al. · Journal of Clinical Oncology · 2019 · 259 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Guido Ghilardi, Joseph A. Fraietta, James N. Gerson et al. · Nature Medicine · 2024 · 256 citations

Life Sciences, Immunology, Oncology +16